Por qu desaparecen los frmacos GLP-1
June 1, 2026: Eli Lilly Files to Exclude Testimony and Dismiss Lawsuits The maker of Zepbound, Eli Lilly, has asked for lawsuits in the GLP-1 MDL to be dismissed
Entre ellos, la carne roja, el pescado, el pollo o los lcteos
Santi C, Scimmi C, Sancineto L (2021) Ebselen and analogues: pharmacological properties and synthetic strategies for their preparation
2018 Jan;137(2):119-29
Ultrasound lymph nodes with metastatic disease may have an irregular, hypoechoic or lobulated appearance CT imaging modality of choice to assess for nodal metastases increased regional nodal size and nodal heterogeneity have implications for metastatic disease Thoracic metastases The lungs and pleura are the second most common site of malignant melanoma metastases after lymph node involvement, with 85% of end-stage melanoma patients having evidence of lung metastases at autopsy